Retinal vasculitis

International Ophthalmology Clinics

Volumn 45, Issue 2, 2005, Pages 99-113

  Levy Clarke, Grace A ^a   Nussenblatt, Robert ^a  

^a NATIONAL EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; AZATHIOPRINE; CARDIOLIPIN ANTIBODY; CORTICOSTEROID; CYCLOSPORIN; DACLIZUMAB; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

BEHCET DISEASE; BORRELIA INFECTION; CLINICAL FEATURE; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; EALES DISEASE; EYE DISEASE; HUMAN; IMMUNOHISTOCHEMISTRY; LASER COAGULATION; LEPROSY; LYME DISEASE; MULTIPLE SCLEROSIS; PATHOGENESIS; POLYARTERITIS NODOSA; PRIORITY JOURNAL; RETINA VASCULITIS; REVIEW; SARCOIDOSIS; SEROLOGY; SYPHILIS; SYSTEMIC LUPUS ERYTHEMATOSUS; TOXOCARIASIS; TOXOPLASMOSIS; TUBERCULOSIS; UVEITIS; VIRUS INFECTION; WEGENER GRANULOMATOSIS; YAWS;

GLUCOCORTICOIDS; HUMANS; RETINAL VASCULITIS;

EID: 17644385545     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.iio.0000155905.95303.1d     Document Type: Review

References (68)

1. Abu el-Asrar AM, Tabbara KF. Retinal vasculitis. Curr Opin Ophthalmol. 1997;8:68-79.
2. Perez-Alvarez AF, Jimenez-Alonso J, Reche-Molina I, et al. Retinal vasculitis and vitreitis in a patient with chronic hepatitis C virus. Arch Intern Med. 2001;161:2262.
3. Kuo Y-H, Yip Y, Chen S-N. Retinal vasculitis associated with chickenpox. Am J Ophthalmol. 2001;132:584-585.
4. Kaiser PK, Lee MS, Martin DA. Occlusive vasculitis in a patient with concomitant West Nile virus infection. Am J Ophthalmol. 2003;136:928-930.
5. Levy-Clarke GA, Buggage RR, Shen D, et al. Human T-cell lymphotropic virus type-1 associated T-cell leukemia/lymphoma masquerading as necrotizing retinal vasculitis. Ophthalmology. 2002;109:1717-1722.
6. Nussenblatt RB, Whitcup SM. Uveitis, Fundamentals and Clinical Practice. St. Louis, MO: Mosby; 2004.
7. Ushiyama O, Ushiyama K, Koarada S, et al. Retinal diseases in patients with systemic lupus erythematosus. Ann Rheum Dis. 2000;59:705-708.
8. Gold DH, Morris DA, Hendkind P. Ocular findings in systemic lupus erythematosus. Br J Ophthalmol. 1972;56:800-804.
9. Morgan CM, Foster CS, Gragoudas ES. Retinal vasculitis in polyarteritis nodosa. Retina. 1986;6:205-209.
10. Rucker CW. Sheathing of the retinal veins in multiple sclerosis. JAMA. 1945;127:970-973.
11. Breger BC, Leopold IH. The incidence of uveitis in multiple sclerosis. Am J Ophthalmol. 1966;62:540-545.
12. Klippel JH, Weyand CM, Wortmann RL. Primer on the Rheumatic Diseases. Atlanta, GA: Arthritis Foundation; 1997.
13. Jabs DA, Fine SL, Hochberg MC, et al. Severe vaso-occlusive disease in systemic lupus erythematosus. Arch Ophthalmol. 1986;104:558-563.
14. Love PE, Santoro SA. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Ann Intern Med. 1990;112:682-689.
15. Out HJ, DeGroot PH, Hasselaar P, et al. Fluctuations of anticardiolipin antibody levels in patients with systemic lupus erythematosus: a prospective study. Ann Rheum Dis. 1989;48:1023-1028.
16. Fauci AS, Haynes BF, Katz P. The spectrum of vasculitis. Clinical, pathologic, immunologic, and therapeutic considerations. Ann Intern Med. 1978;89:660-676.
17. Vianna JL, Khamashta MA, Ordi-Ros J, et al. Comparison of the primary and secondary antiphospholipid syndrome: a European multicenter study of 114 patients. Am J Med. 1994;96:3-9.
18. Goldberg SN, Greco TP. A family study of anticardiolipin antibodies and associated clinical correlations. Am J Med. 1995;69:473-479.
19. Hall S, Buettner H, Luthra HS. Occlusive retinal vascular disease in systemic lupus erythematosus. J Rheumatol. 1984;11:846-850.
20. Ermakova NA, Alekberova ZS, Koshelva NM, et al. Characteristics of retinal vascular involvement in systemic lupus erythematosus. Vestn Oflalmol. 2001;117:21-24.
21. Bullen CL, Liesegang TJ, McDonald TJ, et al. Ocular complications of Wegener's granulomatosis. Ophthalmology. 1983;90:279-290.
22. Haynes BF, Fishman ML, Fauci AS, et al. The ocular manifestations of Wegener's granulomatosis. Fifteen years' experience and review of the literature. Am J Med. 1977;63:121-141.
23. Fauci AS, Haynes BF, Katz P, et al. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med. 1983;98:76-85.
24. Stillerman ML. Ocular manifestations of diffuse collagen disease. Arch Ophthalmol. 1951;45:239-250.
25. Iida T, Spaide RF, Kantor J. Retinal and choroidal arterial occlusion in Wegener's granulomatosis. Am J Ophthalmol. 2002;133:151-152.
26. Akova YA, Jabbur NS, Foster CS. Ocular presentation of polyarteritis nodosa. Clinical course and management with steroid and cytotoxic therapy. Ophthalmology. 1993;100:1775-1781.
27. Hsu CT, Kerrison JB, Miller NR, et al. Choroidal infarction, anterior ischemic optic neuropathy, and central retinal artery occlusion from polyarteritis nodosa. Retina. 2001;21:348-351.
28. Willerson D, Aaberg TM, Reeser FH. Necrotizing vaso-occlusive retinitis. Am J Ophthalmol. 1977;84:209-219.
29. Holland GN. Executive Committee of the American Uveitis Society: standard diagnostic criteria for the acute retinal necrosis syndrome. Am J Ophthalmol. 1994;117:663-666.
30. Fisher JP, Lewis ML, Blumenkranz M, et al. The acute retinal necrosis syndrome. I. Clinical manifestations. Ophthalmology. 1982;89:1309-1316.
31. Helm CJ, Holland GN. Ocular tuberculosis. Surv Ophthalmol. 1993;38:229-256.
32. Hoh HB, Kong VY, Jaais F. Tuberculous retinal vasculitis. Med J Malaysia. 1998;53:288-289.
33. Schlaegel TF Jr, O'Connor GR. Tuberculosis and syphilis. Arch Ophthalmol. 1981;99:2206-2207.
34. Vedy J, Graveline J. Précis D'ophthalmologie Tropicale. Marseille: Diffusion Generale de Libraire; 1979:125.
35. Chovet M, Metge P, Fauxpoint B, et al. Uveite posterieure lepreuse. Bull Soc Ophtalmol Fr. 1976;12:1215-1217.
36. Mendelsohn AD, Jampol LM. Syphilitic retinitis: a cause of necrotizing retinitis. Retina. 1985;4:221-234.
37. Jumper JM, Machemer R, Gallemore RP, et al. Exudative retinal detachment and retinitis associated with acquired syphilitic uveitis. Retina. 2000;20:190-194.
38. Scholes GN, Teske M. Lyme disease and pars planitis. Ophthalmology. 1989;107(Suppl):126.
39. Whitcup SM, Raizman MB. Spirochetal infections and the eye. In: Albert DM, Jakobiec FA, eds. Principles and Practice of Ophthalmology. Vol 5. Philadelphia, PA: W. B. Saunders; 1984:3078-3092.
40. Bialasiewicz AA, Ruprecht KW, Nauman GOH, et al. Bilateral diffuse choroiditis and exudative retinal detachment with evidence of lyme disease. Am J Ophthalmol. 1988;105:419-420.
41. Upadhyay M, Rai NC. Toxocara granuloma of the retina. Jpn J Ophthalmol. 1980;24:278-281.
42. Rubin ML, Kaufman HE, Tiernay JP, et al. An intrretinal nematode. Trans Am Acad Ophthalmol Otolaryngol. 1968;72:855-866.
43. Brown GC, Tasman WS. Retinal arterial obstruction in association with presumed Toxocariasis canis neuroretinitis. Ann Ophthalmol. 1981;13:1385-1387.
44. Tandon R, Menon V, Das GK, et al. Toxoplasmic papillitis with central retinal artery occlusion. Can J Ophthalmol. 1995;30:374-376.
45. Hayashi S, Kim MK, Belfort R Jr. White-centered retinal hemorrhages in ocular toxoplasmosis. Retina. 1997;17:351-352.
46. Rose GE. Papillitis, retinal neovascularization and recurrent retinal vein occlusion in Toxoplasma retinochoroiditis: a case report with uncommon clinical signs. Aust N Z J Ophthalmol. 1991;19:155-157.
47. Pakalin S, Arnaud B. Arterial occlusion associated with toxoplasmic chorioretinitis. J Fr Ophtalmol. 1990;13:554-55.6.
48. Theodossiadis P, Kokolakis S, Ladas I, et al. Retinal vascular involvement in acute toxoplasmosic retinochoroiditis. Int Ophthalmol. 1995;19:19-24.
49. Das T, Biswas J, Kumar A, et al. Eales' disease. Indian J Ophthalmol. 1994;42:3-18.
50. Ryan SJ, Maumenee AE. Birdshot retinochoroidopathy. Am J Ophthalmol. 1980;89:31-45.
51. Gass JMD. Vitiliginous chorioretinitis. Arch Ophthalmol. 1981;99:1778-1787.
52. Bloch-Michel E, Frau E. Birdshot retinochoroidopathy and HLA-A29+ and HLA-A29-idiopathic retinal vasculitis: comparative study of 56 cases. Can J Ophthalmol. 1991;26:361-366.
53. Chan CC, Wetzig RP, Palestine AG, et al. Immunohistopathology of ocular sarcoidosis. Arch Ophthalmol. 1987;105:1398-1402.
54. George RK, Chan CC, Whitcup SM, et al. Ocular immunopathology of Behçet's disease. Surv Ophthalmol. 1997;42:157-162.
55. Winter F, Yukins R. The ocular pathology of Behcet's disease. Am J Ophthalmol. 1966;62:257-262.
56. Reinsh CL, Moyer CF. Animal models of vasculitis. In: Churg A, Churg J, eds. Systemic Vasculitis, the Biologic Basis. New York, NY: Igaku-Shoin; 1991:31-40.
57. Sundy JS, Haynes BF. Pathogenic mechanisms of vessel damage in vasculitis syndromes. Rheum Dis Clin North Am. 1995;21:861-881.
58. Christian CL, Sergent JS. Vasculitis syndromes: clinical and experimental models. Am J Med. 1976;61:385-392.
59. Klok AM, Geertzen R, Rothova A, et al. Anticardiolipin antibodies in uveitis. Curr Eye Res. 1992;11(Suppl):209-213.
60. George RK, Walton RC, Whitcup SM, et al. Primary retinal vasculitis: systemic associations and diagnostic evaluation. Ophthalmology. 1996;103:384-389.
61. Jabs DA, Rosenbaum JT, Foster CS, et al. Perspective. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol. 2000;130:492-513.
62. Nussenblatt RB, Palestine A, Chan CC. Cyclosporin A therapy in the treatment of intraocular inflammatory disease resistant to systemic corticosteroid and cytotoxic agents. Am J Ophthalmol. 1983;96:275-282.
63. Nussenblatt R, Palestine A, Chan C, et al. Effectiveness of cyclosporin therapy for Behcet's disease. Arthritis Rheum. 1985;28:671-679.
64. Shah SS, Lowder CY, Schmitt MA, et al. Low-dose methotrexate therapy for ocular inflammatory disease. Ophthalmology. 1992;99:1419-1423.
65. Larkin G, Lightman S. Mycophenolate mofetil. A useful immunosuppressive in inflammatory eye disease. Ophthalmology. 1999;106:370-374.
66. Fauci AS, Haynes BF, Katz P, et al. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med. 1983;98:76-85.
67. Cuchacovich M, Verdaguer JI, Gatica H, et al. Treatment of ocular inflammatory disease with glucocorticoids and cyclophosphamide pulses. Rev Med Chil. 1995;123:865-873.
68. Nussenblatt RB, Thompson DJ, Li Z, et al. Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety activity data for establishing parameter for subcutaneous administration. J Autoimmun. 2003;21:283-293.